These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2394036)

  • 1. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
    Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
    Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
    Senaldi G; Lupoli S; Vergani D; Black CM
    Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in neonatal infection.
    Peakman M; Senaldi G; Liossis G; Gamsu HR; Vergani D
    Arch Dis Child; 1992 Jul; 67(7 Spec No):802-7. PubMed ID: 1519979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by cellulosic dialysis membranes.
    Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
    J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and alternative complement pathway activation in paracoccidioidomycosis.
    de Messias IT; Mohren D
    J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
    Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
    Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in severe Plasmodium falciparum malaria.
    Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
    Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in C3, C4, factor B, and related metabolites in septic shock.
    Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
    Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the complement system in primary sclerosing cholangitis.
    Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
    Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.